Topic 8 Management of postop bleeding Flashcards
Heparin that becomes protein bound:
-Unavailable for reversal
-May become free post-CPB
“HEPARIN REBOUND”
Excess Protamine induces
Induce bleeding
Hemodilution what % decrease is there in circulating factors ?
Appx 25-35% decrease in circulating factors
Institution dependent
Sources of Post Op Bleeding (7)
-Reduced concentration of coagulation factors -Hyperfibrinolysis -Thrombocytopenia -Impaired Platelet Aggregation -Platelet Fragmentation -Loss of Membrane Receptors -Increased inflammation after CPB impairs coagulation and increases blood loss
Extrinsic Factor of Post Op Bleeding (4)
- Residual Heparin / Heparin Rebound
- Excessive Protamine
- Hemodilution
- Hypothermia
Prevention of Post-Op Bleeding
- Avoiding CPB
- Improved biocompatibility of foreign surfaces
- Alter conduct of bypass
- Use hematologic strategies
- Harvest whole blood / Plasma/PRP
- Improved surgical technique
- Making sure labs are normal pre-op
Heparin has mild fibrinolytic effect
-Stimulates release of serum urokinase
plasminogen activator (UPA)
-Induces fibrinolysis
Tissue Plasminogen Activator (TPA)
-More potent than UPA.
-Primary activator of fibrinolysis during
heart surgery.
Large surge of what after protamine is
given
TPA
At the time of greatest thrombin production
If left unchecked, could result in large scale
clotting or diffuse intravascular
coagulation.
TPA (i.e.. No fibrinolysis)
Thrombin Produced/Surges when?
- Produced throughout CPB
- Surge @ termination of bypass
- Surge after protamine administration
Thrombin
-Amplifier protein
-Activates many cell lines
-Inflammation
-Coagulation
-Fibrinolysis
-Metabolically active in sites where
heparin cannot reach it
Plasminogen Activator Inhibitor 1 (PAI-1)
- regulates? - released by?
- Regulates TPA
- Released by Liver and Endothelial Cells
Plasminogen Activator Inhibitor 1 (PAI-1)
-binds to what?
- PAI-1 binds to TPA as it’s exported from endothelial cells
- Therefore, TPA must over comecirculating
- Initiate fibrinolysis
- Buffer to surges of TPA
- Released in response to inflammatory mediators
Plasminogen Activator Inhibitor 1 (PAI-1)
- is Prothrombic
-Overcomes and suppresses fibrinolytic effect
of TPA
How does PAI-1 overcomes and supresses finbrinolytic effect of TPA?
-Thrombin–makes clot
-TPA breaks up clot PAI-1 prevents TPA from breaking down clots
›Hemostasis!
TPA directly cleaves ?
plasminogen-> Plasmin
When TPA cleaves plasminogen to plasmin what happens? (3)
- Exposes Lysine binding sites
- Fibrinogen and fibrin bind @ these lysine binding sites
- Proteolytic attack leads to breakdown products
TPA breaks apart what?
- Breaks apart fibrin and therefore, the clot
- Leads to post-op bleeding
Fibrin
crosslinks platelets to make a clot
Antifibrinolytic Agents
Lysing Analogs
›Aminocaproic Acid (ACA) / Amicar
›Tranexamic Acid (TA)
Aprotinin
Antifibrinolytic Agents
Lysing Analogs
›Aminocaproic Acid (ACA) / Amicar ›Tranexamic Acid (TA)
Aminocaproic Acid (ACA) / Amicar
Antifibrinolytic Agents
- 2 lysine molecules stuck together
- Competitively binds to lysine sites of plasminogen/ plasmin
- Prevents Plasmin from binding to fibrinogen/fibrin
Aprotinin is?
Antifibrinolytic Agent
- 58 amino acid polypeptide
- Single Lysine>High affinity for plasmin at this site
- Non-specific serine protease inhibitor
- Has other actions
Aprotinin catalyzes what?
Catalyzes multiple reactions of inflammation,
coagulation, and other cellular attack mechanisms
2 commercially available lysine analogs
ACA and TA
Clinically available for 40+ years